Literature DB >> 12908713

Serum cotinine as a marker of environmental tobacco smoke exposure in epidemiological studies: the experience of the MATISS project.

F Seccareccia1, P Zuccaro, R Pacifici, P Meli, F Pannozzo, K M Freeman, A Santaquilani, S Giampaoli.   

Abstract

To describe serum cotinine levels in a rural Italian population and to examine its usefulness as an epidemiologic biomarker of nicotine exposure, cross-sectional data collected in 1993 for the MATISS Project (2098 men and 1352 women, aged 20-79 years) were used. The study population consisted of 977 current smokers, 882 nonsmokers reporting exposure to environmental tobacco smoke (ETS) and 1520 nonsmokers reporting no ETS exposure. Mean values of serum cotinine measured by radioimmunoassay for never smokers, ex-smokers and current smokers (including four categories of cigarette consumption), and for categories of ETS exposure in all nonsmokers were calculated. In univariate analysis, there was a positive association between self-reported nicotine exposure and serum cotinine levels in all groups. Using self-reported status as truth, sensitivity and specificity for various cotinine cutoff points were estimated to distinguish nonsmokers from smokers. The value of 15 ng/mL represented the best combined levels of sensitivity (95%) and specificity (96%). Using this cutoff point, the overall misclassification rate for self-reported nonsmokers was 2.1% and about two times greater for the more vs. the less educated. In multivariate analysis, reported ETS exposure among nonsmokers was significantly associated with serum cotinine even after adjusting for age, socio-demographic and behavioural factors, though the strength of the association was not strong. In conclusion, serum cotinine represents a reliable epidemiological marker of nicotine intake and may be helpful when studying ETS exposure. Improved information collection is needed to reduce misclassification among nonsmokers and enhance our understanding of the relationship between ETS and cotinine measures.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12908713     DOI: 10.1023/a:1024672522802

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  23 in total

1.  Environmental tobacco smoke furthers progression of diabetic nephropathy.

Authors:  David M Obert; Ping Hua; Meagan E Pilkerton; Wenguang Feng; Edgar A Jaimes
Journal:  Am J Med Sci       Date:  2011-02       Impact factor: 2.378

2.  Smoking exacerbates amyloid pathology in a mouse model of Alzheimer's disease.

Authors:  Ines Moreno-Gonzalez; Lisbell D Estrada; Elisabeth Sanchez-Mejias; Claudio Soto
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

3.  Validation of self-reported smokeless tobacco use by measurement of serum cotinine concentration among US adults.

Authors:  Israel T Agaku; Brian A King
Journal:  Am J Epidemiol       Date:  2014-08-13       Impact factor: 4.897

4.  Workplace secondhand smoke exposure in the U.S. trucking industry.

Authors:  Yueh-Hsiu Chiu; Jaime E Hart; Donna Spiegelman; Eric Garshick; Thomas J Smith; Douglas W Dockery; S Katharine Hammond; Francine Laden
Journal:  Environ Health Perspect       Date:  2010-02       Impact factor: 9.031

5.  Developmental cigarette smoke exposure II: Hippocampus proteome and metabolome profiles in adult offspring.

Authors:  Rachel E Neal; Rekha Jagadapillai; Jing Chen; Cindy Webb; Kendall Stocke; Robert M Greene; M Michele Pisano
Journal:  Reprod Toxicol       Date:  2016-05-18       Impact factor: 3.143

6.  A community-based study on determinants of circulating markers of cellular immune activation and kynurenines: the Hordaland Health Study.

Authors:  D Theofylaktopoulou; Ø Midttun; A Ulvik; P M Ueland; G S Tell; S E Vollset; O Nygård; S J P M Eussen
Journal:  Clin Exp Immunol       Date:  2013-07       Impact factor: 4.330

Review 7.  Lung cancer in never smokers: molecular profiles and therapeutic implications.

Authors:  Charles M Rudin; Erika Avila-Tang; Curtis C Harris; James G Herman; Fred R Hirsch; William Pao; Ann G Schwartz; Kirsi H Vahakangas; Jonathan M Samet
Journal:  Clin Cancer Res       Date:  2009-09-15       Impact factor: 12.531

8.  The effects of secondhand smoke on postoperative pain and fentanyl consumption.

Authors:  Mustafa Said Aydogan; Erdogan Ozturk; Mehmet Ali Erdogan; Aytac Yucel; Mahmut Durmus; Mehmet Ozcan Ersoy; Cemil Colak
Journal:  J Anesth       Date:  2013-02-09       Impact factor: 2.078

9.  Correlation between Cigarette Smoking and Urine Cotinine Level in Gastric Cancer Patients.

Authors:  Nima Babhadiashar; Masoud Sotoudeh; Ebrahim Azizi; Jafar Bashiri; Reza Didevar; Reza Malekzadeh; Mohammad Hossein Ghahremani
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

10.  Assessment of smoking status based on cotinine levels in nasal lavage fluid.

Authors:  Mehmet Hakan Ozdener; Karen K Yee; Ryan McDermott; Beverly J Cowart; Aldona A Vainius; Pamela Dalton; Nancy E Rawson
Journal:  Tob Induc Dis       Date:  2009-07-03       Impact factor: 2.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.